Literature DB >> 16170318

Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells.

Ayelet Dar1, Polina Goichberg, Vera Shinder, Alexander Kalinkovich, Orit Kollet, Neta Netzer, Raanan Margalit, Marion Zsak, Arnon Nagler, Izhar Hardan, Igor Resnick, Antal Rot, Tsvee Lapidot.   

Abstract

Regulation of the availability of chemokine SDF-1 (CXCL12) in bone marrow is still not fully understood. Here we describe a unique function for the chemokine receptor CXCR4 expressed on bone marrow endothelial cells, which efficiently internalize circulating SDF-1, resulting in its translocation into the bone marrow. Translocated SDF-1 increased the homing of transplanted human CD34(+) hematopoietic progenitors to the bone marrow. The chemokine transporter function of CXCR4 was a characteristic of endothelial and stromal cells but not of hematopoietic cells. Thus, chemokine translocation across the blood-bone marrow barrier allows effective transfer of functional SDF-1 from the periphery to the stem cell niche in the bone marrow during both homeostasis and 'alarm' situations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170318     DOI: 10.1038/ni1251

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  109 in total

Review 1.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

2.  CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.

Authors:  Gregory C Wilson; Christopher M Freeman; Joshua W Kuethe; Ralph C Quillin; Hiroyuki Nojima; Rebecca Schuster; John Blanchard; Michael J Edwards; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-02-26       Impact factor: 4.052

Review 3.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

Review 5.  Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells.

Authors:  S Sell
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

6.  G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure.

Authors:  Yan Lei; Zhengwen Liu; Qunying Han; Wen Kang; Lei Zhang; Sai Lou
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

7.  Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits.

Authors:  Bai-Chin Lee; Hsiu-Ching Hsu; Wen-Yih I Tseng; Ching-Yi Chen; Hung-Ju Lin; Yi-Lwun Ho; Ming-Jai Su; Ming-Fong Chen
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

8.  CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.

Authors:  Yan-Xi Sun; Elisabeth A Pedersen; Yusuke Shiozawa; Aaron M Havens; Younghun Jung; Jingcheng Wang; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

9.  Interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome.

Authors:  Jin Zhou; Longhu Hu; Zhe Cui; Xian Jiang; Guifang Wang; Geoffrey W Krissansen; Xueying Sun
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

10.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.